---
$id: https://graph.org.ai/products/commodity/41131719
$type: Product
source: UNSPSC
code: "41131719"
title: "Glycosylated hemoglobin assay"
class: "41131700"
classTitle: "Hematology kits and packages"
family: "41130000"
familyTitle: "Blood manufacturing and hematology systems, components and supplies"
segment: "41000000"
segmentTitle: "Laboratory and Measuring and Observing and Testing Equipment"


---

# Glycosylated hemoglobin assay

**UNSPSC Code**: 41131719
**Class**: [Hematology kits and packages](Hematology kits and packages.mdx)
**Family**: [Blood manufacturing and hematology systems, components and supplies](../Blood manufacturing and hematology systems, components and supplies.mdx)
**Segment**: [Laboratory and Measuring and Observing and Testing Equipment](../../Laboratory and Measuring and Observing and Testing Equipment.mdx)

In this classification a glycosylated hemoglobin assay is a device used to measure the glycosylated hemoglobins (A1a, A1b, and A1c) in a patient's blood by a column chromatographic procedure. Measurement of glycosylated hemoglobin is used to assess the level of control of a patient's diabetes and to determine the proper insulin dosage for a patient. Elevated levels of glycosylated hemoglobin indicate uncontrolled diabetes in a patient US FDA regulates Glycosylated hemoglobin assay under 21 CFR 864.7470 and under FDA product code LCP.

